Profile image
By Midas Letter (Reporter)
Contributor profile | More stories
Story Views
Last Hour:
Last 24 Hours:

Canopy Rivers Inc (CVE:RIV) Ventures Into Agri-Technologies in Latest Investment

% of readers think this story is Fact. Add your two cents.

biolumic canopy rivers

Canopy Rivers Inc (CVE:RIV) (OTCMKTS:CNPOF) is treading new investment ground internationally. This morning, the cannabis venture/incubator portfolio company announced an investment in a jurisdiction not generally known as an industry player.

The company’s investment in New Zealand-based BioLumic Ltd.—a purveyor of ultraviolet (UV) light to empower growers and seed producers around the globe—vests Canopy Rivers in an area few others have ventured to date. According to the release, BioLumic extended a Finistere Ventures-led Series A financing round to include Canopy Rivers’ strategic investment of US$1.5 million, closing the oversubscribed round at US$6.7 million. The financing wasn’t just comprised of wealthy accredited investors; smaller funds such as the Rabo Food & Agri Innovation Fund—a Rabobank Group umbrella company ($750B in assets)—also participated. 

Finistere Ventures, itself, is supported by industry leaders like Bayer AG and Nutrien, and works closely with its network in the agriculture space to help commercialize innovations at a global scale.

This marks Canopy Rivers’ first investment in agri-technologies, specifically focused on the emerging fields of plant physiology and UV photobiology. BioLumic will use its newfound capital to grow its operations to support the acceleration and expansion of its UV light treatment initiatives—including applications in the medical cannabis market. BioLumic’s UV light treatments are purported to deliver long-term crop benefits such as improved crop consistency, increased yield, drought tolerance, and disease and pest resistance. 

Today’s announcement marks a continuance of an uptick in recent news flow, which has buffered Canopy Rivers from the market’s latest downdraft. Over the past 4-sessions, RIV gained 18.91% following portfolio company Pharmhouse Inc. announcing a significant supply agreement between it and Canopy Growth. Over the past month, aggregate gains are similar. A combination of portfolio company news and direct-equity investments are keeping the news cycle humming.

Midas Letter will have further coverage as events warrant.

Original article: Canopy Rivers Inc (CVE:RIV) Ventures Into Agri-Technologies in Latest Investment

©2019 Midas Letter. All Rights Reserved.

Support BeforeitsNews by trying our natural health products! Join our affiliate program

APeX - Far superior to colloidal silver in destroying viruses, bacteria and other pathogens.
Ultimate Curcumin - Natural pain relief, reduce inflammation and so much more.
Supreme Fulvic - Nature's most important supplement! Vivid Dreams again!  See Testimonials
MitoCopper - First bioavailable copper destroys pathogens and gives you more energy.
Prodovite - The Secret To Healing is in the Blood! Complete absorption in 5 minutes.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.